REUTERS: Vertex Pharmaceuticals said on Wednesday it selected two next-generation cystic fibrosis drugs to advance into late-stage testing of triple-combination therapies that could eventually treat up to 90 percent of patients with the life-shortening lung disease. Its currently approved ...
- Commuters Complain Of Mystery Stench Along North-South And East-West Lines
- PSA: Qoo10 Warns Of Scam To Get Your Credit Card Information
- Why “S’pore is not a repressive country”
- WATCH: Some jackass throwing himself onto vehicles in a rampage along Geylang Road
- Enjoy a world of Micheline-starred delights at MMI Savour Gourmet Festival 2018
- These 4 Singapore companies could benefit from consumption growth in Asia
- Low budget fun family activities this June holidays